Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Depreciation & Amortization (CF) (2017 - 2025)

Catheter Precision (VTAK) has disclosed Depreciation & Amortization (CF) for 9 consecutive years, with $527000.0 as the latest value for Q4 2025.

  • Quarterly Depreciation & Amortization (CF) fell 0.75% to $527000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.1 million through Dec 2025, changed 0.28% year-over-year, with the annual reading at $2.1 million for FY2025, 0.28% changed from the prior year.
  • Depreciation & Amortization (CF) for Q4 2025 was $527000.0 at Catheter Precision, roughly flat from $528000.0 in the prior quarter.
  • The five-year high for Depreciation & Amortization (CF) was $1.4 million in Q1 2023, with the low at -$406000.0 in Q2 2023.
  • Average Depreciation & Amortization (CF) over 5 years is $414250.0, with a median of $518500.0 recorded in 2023.
  • Peak annual rise in Depreciation & Amortization (CF) hit 1968.0% in 2023, while the deepest fall reached 398.53% in 2023.
  • Over 5 years, Depreciation & Amortization (CF) stood at $315000.0 in 2021, then crashed by 92.06% to $25000.0 in 2022, then skyrocketed by 1968.0% to $517000.0 in 2023, then grew by 2.71% to $531000.0 in 2024, then decreased by 0.75% to $527000.0 in 2025.
  • According to Business Quant data, Depreciation & Amortization (CF) over the past three periods came in at $527000.0, $528000.0, and $529000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.